Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 138 | $77,751,392 |
Sells | 179 | $97,046,544 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 1,653 | 246.0123 | 406,658 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 23 Dec 2022 | Sale | 1,500 | 272.74 | 409,110 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 1,600 | 257.9347 | 412,696 | D |
15 Nov 2023 17:13 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 2,658 | 156.4244 | 415,776 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,144 | 136.1805 | 428,151 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 2,994 | 145.9775 | 437,057 | I |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 1,549 | 283.85 | 439,684 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 2,877 | 153.2523 | 440,907 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 1,821 | 246.3097 | 448,530 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,672 | 274.57 | 459,081 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 1,600 | 290.36 | 464,576 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 2,190 | 213.8548 | 468,342 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 2,204 | 228.7893 | 504,252 | I |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 1,800 | 280.66 | 505,188 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 3,693 | 136.9089 | 505,605 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 2,079 | 244.4509 | 508,213 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 2,080 | 244.965 | 509,527 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 2,078 | 245.7126 | 510,591 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 1,913 | 268.5 | 513,640 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 2,089 | 246.3249 | 514,573 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 2,373 | 218.4583 | 518,402 | I |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 01 Mar 2023 | Sale | 1,928 | 273.44 | 527,192 | D |
18 Jun 2024 21:39 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 14 Jun 2024 | Sale | 1,900 | 280 | 532,000 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 2,104 | 258.2412 | 543,339 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 3,542 | 154.5969 | 547,582 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 2,294 | 243.6447 | 558,921 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,069 | 270.56 | 559,789 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,084 | 271.54 | 565,889 | D |
14 Jun 2024 21:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 12 Jun 2024 | Sale | 2,000 | 285 | 570,000 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 3,022 | 189.6978 | 573,267 | I |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 2,038 | 285.74 | 582,338 | D |
01 Dec 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 29 Nov 2023 | Sale | 3,000 | 199.45 | 598,350 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 2,549 | 245.1381 | 624,857 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 2,873 | 217.9078 | 626,049 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 4,631 | 137.6855 | 637,622 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 2,634 | 243.6849 | 641,866 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 2,734 | 245.0643 | 670,006 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,471 | 273.54 | 675,917 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 2,325 | 295.45 | 686,921 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 5,072 | 140.9024 | 714,657 | I |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 2,790 | 257.3262 | 717,940 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 4,151 | 173.2016 | 718,960 | I |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 2,991 | 244.8946 | 732,480 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 2,620 | 279.96 | 733,495 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 2,628 | 282.97 | 743,645 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 3,085 | 242.7114 | 748,765 | D |
06 Jan 2023 09:08 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LYNCH BRIAN JOSEPH | SVP and General Counsel | 03 Jan 2023 | Sale | 2,656 | 281.97 | 748,912 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 3,019 | 274.56 | 828,897 | D |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 3,003 | 279.15 | 838,287 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 3,857 | 221.2418 | 853,330 | I |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 3,464 | 247.7601 | 858,241 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 4,923 | 175.7185 | 865,062 | I |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 4,712 | 187.2707 | 882,420 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Dec 2023 | Purchase | 3,960 | 229.8647 | 910,264 | I |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 3,730 | 244.1197 | 910,566 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 4,895 | 187.345 | 917,054 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 6,022 | 152.48 | 918,235 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 6,369 | 145.4592 | 926,430 | I |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 3,604 | 257.2981 | 927,302 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 3,966 | 244.2228 | 968,588 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 3,325 | 291.66 | 969,770 | D |
14 Dec 2023 18:09 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 12 Dec 2023 | Purchase | 4,408 | 220.6546 | 972,645 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 4,518 | 219.8652 | 993,351 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 03 Apr 2024 | Sale | 4,070 | 244.6815 | 995,854 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 3,900 | 256.881 | 1,001,836 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 4,532 | 221.7787 | 1,005,101 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 4,200 | 240.8759 | 1,011,679 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 3,548 | 293.54 | 1,041,480 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 03 Apr 2024 | Sale | 4,301 | 244.5847 | 1,051,959 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 5,009 | 211.844 | 1,061,127 | D |
02 Mar 2023 16:30 | MDGL | MADRIGAL PHARMACEUTICALS Inc | WALTERMIRE ROBERT E. | Senior VP, Chief Pharma Dev. | 28 Feb 2023 | Sale | 4,100 | 272.3 | 1,116,430 | D |
03 Apr 2024 20:47 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 01 Apr 2024 | Sale | 4,387 | 255.899 | 1,122,629 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 4,866 | 248.5907 | 1,209,642 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 5,028 | 246.959 | 1,241,710 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 8,098 | 153.9736 | 1,246,878 | I |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 5,594 | 224.9117 | 1,258,156 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 5,228 | 245.346 | 1,282,669 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 5,299 | 242.2492 | 1,283,679 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 20 Nov 2023 | Purchase | 7,010 | 183.3999 | 1,285,633 | I |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 05 Apr 2024 | Sale | 5,278 | 245.5332 | 1,295,924 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | TAUB REBECCA | Pres., R&D, and CMO | 04 Apr 2024 | Sale | 5,619 | 241.8528 | 1,358,971 | D |
10 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 08 Apr 2024 | Sale | 5,663 | 244.8607 | 1,386,646 | D |
21 Nov 2023 18:15 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 21 Nov 2023 | Purchase | 7,917 | 190.1361 | 1,505,308 | I |
28 Dec 2022 20:00 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SUKHIJA REMY | Chief Commercial Officer | 23 Dec 2022 | Sale | 5,534 | 272.68 | 1,509,011 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 04 Apr 2024 | Sale | 6,273 | 241.0684 | 1,512,222 | D |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 5,164 | 294.68 | 1,521,728 | D |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Nov 2023 | Purchase | 10,790 | 141.445 | 1,526,192 | I |
19 Jan 2023 19:57 | MDGL | MADRIGAL PHARMACEUTICALS Inc | LEVY RICHARD S | Director | 17 Jan 2023 | Sale | 5,227 | 292.68 | 1,529,838 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 02 Apr 2024 | Sale | 6,279 | 244.1927 | 1,533,286 | D |
11 Sep 2024 21:51 | MDGL | MADRIGAL PHARMACEUTICALS Inc | SIBOLD WILLIAM JOHN | President and CEO | 09 Sep 2024 | Sale | 6,363 | 243.83 | 1,551,490 | D |
05 Apr 2024 20:50 | MDGL | MADRIGAL PHARMACEUTICALS Inc | FRIEDMAN PAUL A | Director | 05 Apr 2024 | Sale | 6,679 | 242.4162 | 1,619,098 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 6,698 | 255.6165 | 1,712,119 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 02 Apr 2024 | Sale | 7,048 | 244.2722 | 1,721,630 | D |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 6,809 | 255.6366 | 1,740,630 | D |
16 May 2024 21:53 | MDGL | MADRIGAL PHARMACEUTICALS Inc | CRAVES FRED B | Director | 14 May 2024 | Sale | 8,827 | 210.9926 | 1,862,432 | D |
21 Nov 2023 18:14 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 17 Nov 2023 | Purchase | 10,715 | 175.8179 | 1,883,889 | I |
03 Apr 2024 20:41 | MDGL | MADRIGAL PHARMACEUTICALS Inc | DALY JAMES M | Director | 01 Apr 2024 | Sale | 7,401 | 256.5019 | 1,898,371 | D |
03 Apr 2024 20:44 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BATE KENNETH | Director | 01 Apr 2024 | Sale | 7,411 | 256.4904 | 1,900,850 | D |
14 Dec 2023 18:10 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 13 Dec 2023 | Purchase | 9,262 | 222.676 | 2,062,425 | I |
15 Nov 2023 17:12 | MDGL | MADRIGAL PHARMACEUTICALS Inc | BAKER BROS. ADVISORS LP | Director | 14 Nov 2023 | Purchase | 13,548 | 154.7801 | 2,096,961 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)